Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 39 (3) , 233-253
- https://doi.org/10.1016/s0169-5002(02)00454-3
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patientsLung Cancer, 2001
- Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatinCancer, 1999
- Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patientsEuropean Journal Of Cancer, 1998
- Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyEuropean Journal Of Cancer, 1997
- Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Surgical treatment of non‐small cell lung cancer in patients older than seventy yearsJournal of Surgical Oncology, 1995
- Operation for lung cancer in the elderly: What about octogenarians?The Annals of Thoracic Surgery, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Long-term results in the elderly following pulmonary resection for non-small cell lung carcinomaEuropean Journal of Cardio-Thoracic Surgery, 1993
- Radiation therapy for Stage I–III epidermoid carcinoma of the lungLung Cancer, 1992